MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Grifols SA, Barcelona Company Profile (NASDAQ:GRFS)

Consensus Ratings for Grifols SA, Barcelona (NASDAQ:GRFS) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $20.75 (33.87% upside)

Analysts' Ratings History for Grifols SA, Barcelona (NASDAQ:GRFS)
Show:
DateFirmActionRatingPrice TargetActions
6/6/2016Morgan StanleyReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016NomuraInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2016Berenberg BankUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2015HSBCDowngradeBuy -> Hold$22.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/17/2015JPMorgan Chase & Co.Boost Price TargetNeutral$17.50 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2015Goldman SachsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2014Bank of AmericaDowngradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for Grifols SA, Barcelona (NASDAQ:GRFS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
3/12/2015$0.58$0.53ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/18/2014$0.51$0.44ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/15/2014$0.55$0.40ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Grifols SA, Barcelona (NASDAQ:GRFS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.24$0.52$0.38
Q2 20162$0.26$0.55$0.41
Q3 20161$0.53$0.53$0.53
Q4 20161$0.57$0.57$0.57
Q1 20171$0.28$0.28$0.28
Q2 20171$0.30$0.30$0.30
Q3 20171$0.30$0.30$0.30
Q4 20171$0.33$0.33$0.33
(Data provided by Zacks Investment Research)
Dividend History for Grifols SA, Barcelona (NASDAQ:GRFS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/31/2016$0.116/2/20166/6/20166/6/2016Tweet This Announcement  Share This Announcement on StockTwits
12/1/2015$0.3012/10/201512/14/201512/14/2015Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Grifols SA, Barcelona (NASDAQ:GRFS)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Grifols SA, Barcelona (NASDAQ:GRFS)
DateHeadline
06/25/16 08:09 AMWhat's Propelling Grifols SA, Barcelona to Decline So Much? The Stock Gaps Down Today - Engelwood Daily
06/23/16 07:14 AMHC Stocks in Front Line: Incyte Corporation (NASDAQ:INCY), Grifols SA, Barcelona (NASDAQ:GRFS) - share market updates (press release)
06/22/16 10:33 PMGrifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 : By the numbers : June 23, 2016 -
06/22/16 11:54 AMGrifols SA :GRFS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 -
06/21/16 08:55 AMGrifols : FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood Supply Under an IND Study Protocol
06/20/16 08:53 AMZika Blood Screening Test From Hologic, Grifols Gets FDA Nod -
06/20/16 07:00 AMFDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood Supply Under an IND Study Protocol - [PR Newswire] - MARLBOROUGH, Mass. and EMERYVILLE, Calif., June 20, 2016 /PRNewswire/ -- Hologic, Inc. (HOLX) and Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) – market-leading partners committed to blood safety - announced today that the U.S. Food and Drug Administration (FDA) has approved use of the Procleix Zika virus blood screening assay on the Procleix Panther system under the agency's Investigational New Drug (IND) study protocol. Prominent U.S. blood centers will use the Procleix Zika virus assay to screen donated blood collected in potential endemic areas of the southern U.S., and may expand testing to other areas of the U.S. if the virus continues to spread. "The American Red Cross is pleased to participate in the Procleix Zika Virus assay investigational study, which will allow us to begin blood donor testing for Zika virus early this summer in areas most likely to have local mosquito transmission of the virus," said Susan Stramer, Ph.D., Vice President of Scientific Affairs at the American Red Cross.
06/16/16 08:05 AMAnalyzing IBB’s Moving Averages -
06/16/16 12:49 AMGrifols confirms that it has voluntarily signed the EFPIA Code of Conduct - [at noodls] - Barcelona, June 15, 2016. Grifols released its Corporate Social Responsibility policy on May 26, 2016, via the Spanish stock exchange regulator, the CNMV, and announced its decision to voluntarily adopt ...
06/05/16 04:15 PMHow Many Grifols SA, Barcelona (NASDAQ:GRFS)'s Analysts Are Bullish? - HNN
06/03/16 04:29 AMNews Buzz: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), Grifols SA, Barcelona (NASDAQ:GRFS) - NYSE Journal (press release) - News Buzz: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), Grifols SA, Barcelona (NASDAQ:GRFS)NYSE Journal (press release)On Thursday, Shares of Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), added 15.42% and closed at $0.583 in the last trading session. The last trading range of the stock ranges between $0.51 and $0.64. Sunesis Pharmaceuticals, Inc. (SNSS) recently ...and more »
06/01/16 04:36 PMEli Lilly and Co (NYSE:LLY) & Grifols SA, Barcelona (NASDAQ:GRFS) Healthcare Hot Stock's Alert - Wall Street 24 - Eli Lilly and Co (NYSE:LLY) & Grifols SA, Barcelona (NASDAQ:GRFS) Healthcare Hot Stock's AlertWall Street 24On Tuesday, Shares of Eli Lilly and Co (NYSE:LLY) gained 0.05% to $75.03. The share price is trading in a range of $74.71 – $75.63. The stock exchanged hands with 4.44 Million shares contrast to its average daily volume of 4.02 Million shares. The U.S. ...and more »
06/01/16 08:07 AMGrifols Maintains Its Dividend Payout at 40% -
05/31/16 10:07 PMBig East Bay drug company buys into small East Bay diagnostic company - San Francisco Business Times (blog) - San Francisco Business Times (blog)Big East Bay drug company buys into small East Bay diagnostic companySan Francisco Business Times (blog)Spanish drug and diagnostics maker Grifols S.A. will spend $50 million for a 20 percent stake in diagnostics company Singulex Inc. and an exclusive worldwide license for the Alameda company's technology for screening donor blood and plasma. "This new ...Grifols Invests $50 Mln in Singulex Stock in Return For Global License For SMC Screening Technology (NASDAQ:GRFS)Sonoran Weekly Reviewall 4 news articles »
05/31/16 10:32 AMBluecrest Capital Management LTD Increased Grifols S A (NASDAQ:GRFS) by $7.56 Million as Shares Rose - CCH Daily News - Bluecrest Capital Management LTD Increased Grifols S A (NASDAQ:GRFS) by $7.56 Million as Shares RoseCCH Daily NewsGrifols SA, Barcelona (NASDAQ:GRFS) has declined 5.93% since October 22, 2015 and is downtrending. It has underperformed by 8.20% the S&P500. Bluecrest Capital Management Ltd, which manages about $1.62B US Long portfolio, decreased its stake ...and more »
05/31/16 07:26 AMSingulex announces a $50 million investment by Grifols for a 20% stake in the company - [PR Newswire] - ALAMEDA, Calif. and BARCELONA, Spain, May 31, 2016 /PRNewswire/ -- Singulex, Inc., the leader in next generation immunodiagnostic technology powered by single molecule counting, announced today a partnership with Grifols, one of the world's largest plasma product manufacturers and a pioneer in the research and development of therapeutic alternatives designed to contribute to scientific development. Grifols has subscribed a share capital increase and holds a 20% stake in Singulex. The partnership provides Singulex US$50 million in exchange for Grifols' access to an exclusive worldwide license for the use and sale of Singulex' SMC technology for the screening of donor blood and plasma.
05/30/16 01:10 PMWatch-List HC Stocks: Endologix, Inc. (NASDAQ:ELGX), Grifols SA, Barcelona (NASDAQ:GRFS) - share market updates (press release) - Watch-List HC Stocks: Endologix, Inc. (NASDAQ:ELGX), Grifols SA, Barcelona (NASDAQ:GRFS)share market updates (press release)Shares of Endologix, Inc. (NASDAQ:ELGX) ended Friday session in green amid volatile trading. The shares closed up +0.24 points or 1.89% at $12.97 with 1.55 million shares getting traded. Post opening the session at $12.72, the shares hit an intraday ...and more »
05/27/16 12:17 PMHC Stocks News Ring: Grifols SA, Barcelona (NASDAQ:GRFS), Insys Therapeutics Inc (NASDAQ:INSY) - share market updates (press release) - share market updates (press release)HC Stocks News Ring: Grifols SA, Barcelona (NASDAQ:GRFS), Insys Therapeutics Inc (NASDAQ:INSY)share market updates (press release)Shares of Grifols SA, Barcelona (NASDAQ:GRFS) ended Thursday session in green amid volatile trading. The shares closed up +0.18 points or 1.14% at $15.97 with 1.61 million shares getting traded. Post opening the session at $15.84, the shares hit an ...Rock Point Advisors LLC Increased Grifols B Adr (NASDAQ:GRFS) by $3.00 Million as Shares RoseCCH Daily Newsall 5 news articles »
05/27/16 10:47 AMGrifols allocates EUR 213 million to dividends and maintains pay-out at 40% of consolidated net profit Download (222.1 Kb) - [at noodls] - 02f682f4-41d9-4566-bda3-81b36d8ce219.pdf Grifols' Ordinary General Meeting of Shareholders Grifols allocates EUR 213 million to dividends and maintains pay-out at 40% of consolidated net profit The company ...
05/27/16 09:17 AMGrifols allocates EUR 213 million to dividends and maintains pay-out at 40% of consolidated net profit - [at noodls] - The company holds its Ordinary General Meeting of Shareholders at second call, with 81.96% of its share capital represented The shareholders endorse the management team and ratify all the items on the ...
05/25/16 11:06 AMHC Stocks Updates: Grifols SA, Barcelona (NASDAQ:GRFS), GlaxoSmithKline plc (ADR) (NYSE:GSK) - share market updates (press release) - share market updates (press release)HC Stocks Updates: Grifols SA, Barcelona (NASDAQ:GRFS), GlaxoSmithKline plc (ADR) (NYSE:GSK)share market updates (press release)Shares of Grifols SA, Barcelona (NASDAQ:GRFS) ended Tuesday session in green amid volatile trading. The shares closed up +0.34 points or 2.23% at $15.57 with 2.70 million shares getting traded. Post opening the session at $15.14, the shares hit an ...Worth Watching Stocks Buzz: Grifols SA, Barcelona (NASDAQ:GRFS), Kinder Morgan Inc (NYSE:KMI)NYSE Journal (press release)What's Ahead for Grifols SA, Barcelona After Today's Gap Up?Wall Street Hints and Newsall 10 news articles »
05/24/16 11:37 AMWorth Watching Stocks Buzz: Grifols SA, Barcelona (NASDAQ:GRFS), Kinder Morgan Inc (NYSE:KMI) - NYSE Journal (press release) - NYSE Journal (press release)Worth Watching Stocks Buzz: Grifols SA, Barcelona (NASDAQ:GRFS), Kinder Morgan Inc (NYSE:KMI)NYSE Journal (press release)On Monday, Shares of Grifols SA, Barcelona (NASDAQ:GRFS), added 2.63% and closed at $15.23 in the last trading session. The last trading range of the stock ranges between $14.99 and $15.33. Wall Street analysts will commonly offer stock price target ...What's Ahead for Grifols SA, Barcelona After Today's Gap Up?Wall Street Hints and Newsall 7 news articles »
05/24/16 11:37 AMNotable Runners: Grifols SA, Barcelona (NASDAQ:GRFS), Skyworks Solutions Inc (NASDAQ:SWKS) - NYSE Journal (press release) - NYSE Journal (press release)Notable Runners: Grifols SA, Barcelona (NASDAQ:GRFS), Skyworks Solutions Inc (NASDAQ:SWKS)NYSE Journal (press release)Grifols SA, Barcelona (NASDAQ:GRFS) belongs to Healthcare sector and Biotechnology industry. GRFS stock opened its current trade at $15.00 and now is floating in a range of $14.99 to $15.33, trading at $15.31. GRFS stock gain 3.23% in total of its ...and more »
05/19/16 10:57 AMBlack Creek Investment Management INC Increased Grifols Sa (Adr) (NASDAQ:GRFS) by $20.42 Million as Shares Rose - CCH Daily News - Black Creek Investment Management INC Increased Grifols Sa (Adr) (NASDAQ:GRFS) by $20.42 Million as Shares RoseCCH Daily NewsBlack Creek Investment Management Inc increased its stake in Grifols Sa (Adr) (NASDAQ:GRFS) by 94.09% based on its latest 2016Q1 regulatory filing with the SEC. Black Creek Investment Management Inc bought 1.36 million shares as the company's stock ...and more »
05/14/16 05:22 AMEarnings per Share Report: Grifols SA, Barcelona (NASDAQ:GRFS) - News Oracle - News OracleEarnings per Share Report: Grifols SA, Barcelona (NASDAQ:GRFS)News OracleLast Trade: The Company fell -0.13% and finished at $14.88. The daily volume was measured at 1.14 million shares. The 52-week high of the share price is $18.04 and the 52-week low is $14.07. The company has a market cap of $3.90 Billion. Its latest ...
05/13/16 05:31 AMEarnings Overview of the Stock: Grifols SA, Barcelona (NASDAQ:GRFS) - News Oracle - News OracleEarnings Overview of the Stock: Grifols SA, Barcelona (NASDAQ:GRFS)News OracleLast Trade: The Company fell -1.13% and finished at $14.90. The daily volume was measured at 521,250.00 shares. The 52-week high of the share price is $18.04 and the 52-week low is $14.07. The company has a market cap of $3.94 Billion. Its latest ...and more »
05/07/16 05:12 AMPrice Target Summary Report: Grifols SA, Barcelona (NASDAQ:GRFS) - News Oracle - Price Target Summary Report: Grifols SA, Barcelona (NASDAQ:GRFS)News OracleLast Trade: The Company fell -3.91% and finished at $15.24. The daily volume was measured at 2.45 million shares. The 52-week high of the share price is $18.04 and the 52-week low is $14.07. The company has a market cap of $4.15 Billion. Its latest ...
05/05/16 08:41 AMGrifols' revenues increase by +5.6% to Euros 959 million, driven by growth of +10.9% for the Bioscience Division - [at noodls] - The Bioscience Division grows by +10.9% (+6.3% cc) and generates revenues of Euros 754.9 million. Positive growth of sales of the main plasma proteins Recurring revenues (excluding Raw Materials and Others) ...
05/05/16 05:24 AMGrifols' : revenues increase by +5.6% to Euros 959 million, driven by growth of +10.9% for the Bioscience Division Download (256.2 Kb) - driven by growth of +10.9% for the Bioscience Division Barcelona, 5 May 2016.- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) increased its net revenues by +5.6% (+1.5% cc) to Euros 958.9 million in the first quarter of 2016. Recurring sales (excluding ...
05/05/16 02:01 AMGrifols' revenues increase by +5.6% to Euros 959 million, driven by growth of +10.9% for the Bioscience Division Download (256.2 Kb) - [at noodls] - a932c575-1505-4f69-8430-2f6a724e7e29.pdf Grifols' revenues increase by +5.6% to Euros 959 million, driven by growth of +10.9% for the Bioscience Division The Bioscience Division grows by +10.9% (+6.3% ...
05/04/16 03:10 PMETF’s with exposure to Grifols SA : May 4, 2016 -
04/26/16 05:41 AMAnalysis Report: Grifols SA, Barcelona (NASDAQ:GRFS) - News Oracle - Analysis Report: Grifols SA, Barcelona (NASDAQ:GRFS)News OracleLast Trade: The Company rose 0.82% and finished at $15.89. The daily volume was measured at 1.80 million shares. The 52-week high of the share price is $18.04 and the 52-week low is $14.07. The company has a market cap of $4.15 Billion. Its latest ...and more »
04/18/16 10:43 AMThe Catalan Down's Syndrome Foundation and Grifols are working together to promote research - [at noodls] - Grifols has donated 150,000 euros to support the Foundation's research effort, designed to improve the quality of life of people with intellectual disability One of the lines of research, in partnership ...
04/07/16 09:21 AMStocks in Limelight: ACADIA Pharmaceuticals (NASDAQ:ACAD), Grifols SA, Barcelona (NASDAQ:GRFS), Medivation ... - The Point Review - The Point ReviewStocks in Limelight: ACADIA Pharmaceuticals (NASDAQ:ACAD), Grifols SA, Barcelona (NASDAQ:GRFS), Medivation ...The Point ReviewACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) fall 6.66% to reach at $31.89. The company has experienced volume of 1.90 million and trading in the price range of $30.04 – $31.93 for the current session. The sell-side analysts are projecting earnings per ...and more »
04/06/16 04:20 PMETF’s with exposure to Grifols SA : April 6, 2016 -
04/06/16 10:57 AMCIGNA Corporation (NYSE:CI) & Grifols SA, Barcelona (NASDAQ:GRFS) Hot Stock's Alert - Wall Street 24 - CIGNA Corporation (NYSE:CI) & Grifols SA, Barcelona (NASDAQ:GRFS) Hot Stock's AlertWall Street 24On Tuesday, Shares of CIGNA Corporation (NYSE:CI) lost -4.04% to $135.52. The share price is trading in a range of $135.47 – $141.21. The stock exchanged hands with 2.72 Million shares contrast to its average daily volume of 1.09 Million shares.and more »
04/05/16 10:36 AMMid-Day Stocks Update: Gap Inc (NYSE:GPS), Grifols SA, Barcelona (GRFS) - News Oracle - Mid-Day Stocks Update: Gap Inc (NYSE:GPS), Grifols SA, Barcelona (GRFS)News OracleGap Inc (NYSE:GPS) is trading up with a percentage change of 0.92% and is at $29.50 right now. The Company's market capitalization stands at $11.74 Billion in the current trading Session whereas, its outstanding shares are 397.14 Million. Recent Press ...and more »
04/05/16 08:35 AMGrifols could receive more than $12M from county if it meets hiring projections -
04/05/16 06:12 AMGrifols 2015 Annual Report on Form 20-F filed with the SEC on April 5, 2016 - [PR Newswire] - BARCELONA, Spain, April 5, 2016 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS) announced that it has filed its 2015 Annual Report on Form 20-F with the United ...
03/24/16 12:19 PMDon't Miss: Grifols, S.A. (NASDAQ:GRFS), Pepco Holdings, Inc. (NYSE:POM), Charles River Laboratories International ... - KC Register - Don't Miss: Grifols, S.A. (NASDAQ:GRFS), Pepco Holdings, Inc. (NYSE:POM), Charles River Laboratories International ...KC RegisterGrifols, S.A. (NASDAQ:GRFS) upgraded shares of Grifols SA, Barcelona (NASDAQ:GRFS) from a sell rating to a hold rating in a research report report published. Other equities analysts have also recently issued reports about the company. Nomura assumed ...and more »
03/23/16 01:35 PMEuropean Stocks to Focus: Weatherford International (WFT), Grifols SA, Barcelona (GRFS) - News Oracle - European Stocks to Focus: Weatherford International (WFT), Grifols SA, Barcelona (GRFS)News OracleThe company's RSI reading has hit 59.86. The stock edged higher by 0.86% to close previous trading session at USD 7.66. The shares of the company fluctuated in the range of USD 4.95 and USD 14.90 in the course of 52 weeks. Over the three months, the ...and more »
03/17/16 09:54 AMGrifols SA, Barcelona (GRFS) Earns Buy Rating from Analysts at Nomura - MicroCap Magazine - MicroCap MagazineGrifols SA, Barcelona (GRFS) Earns Buy Rating from Analysts at NomuraMicroCap MagazineStock analysts at Nomura began coverage on shares of Grifols SA, Barcelona (NASDAQ:GRFS) in a research note issued to investors on Thursday, The Fly reports. The brokerage set a “buy” rating on the stock. A number of large investors have modified their ...and more »
03/13/16 08:07 PMWere Analysts Bearish Grifols SA, Barcelona (NASDAQ:GRFS) This Week? - RiversideGazette.com - Were Analysts Bearish Grifols SA, Barcelona (NASDAQ:GRFS) This Week?RiversideGazette.comOut of 2 analysts covering Grifols SA (NASDAQ:GRFS), 1 rate it “Buy”, 1 “Sell”, while 1 “Hold”. This means 33% are positive. Grifols SA was the topic in 5 analyst reports since August 17, 2015 according to StockzIntelligence Inc. Below is a list of ...
03/10/16 12:52 PMETF’s with exposure to Grifols SA : March 10, 2016 -
03/07/16 01:41 PMHow Many Grifols SA, Barcelona (NASDAQ:GRFS)'s Analysts Are Bearish? - RiversideGazette.com - How Many Grifols SA, Barcelona (NASDAQ:GRFS)'s Analysts Are Bearish?RiversideGazette.comOut of 2 analysts covering Grifols SA (NASDAQ:GRFS), 1 rate it “Buy”, 1 “Sell”, while 1 “Hold”. This means 33% are positive. Grifols SA was the topic in 5 analyst reports since August 17, 2015 according to StockzIntelligence Inc. Below is a list of ...and more »
03/07/16 11:34 AMGrifols SA :GRFS-US: Earnings Analysis: Q4, 2015 By the Numbers -
02/28/16 05:46 PMGrifols SA, Barcelona (GRFS) EPS Expected to Increase - OctaFinance.com - The Hilltop NewsGrifols SA, Barcelona (GRFS) EPS Expected to IncreaseOctaFinance.comAnalysts await Grifols SA, Barcelona (NASDAQ:GRFS) to reports earnings on February, 29 before the open. They expect $0.27 EPS, up 3.85 % or $0.01 from last year's $0.26 per share. GRFS's profit will be $70.70M for 14.46 P/E if the $0.27 EPS becomes ...Grifols SA, Barcelona (GRFS) Short Interest Up 35.4% in FebruaryThe Hilltop Newsall 4 news articles »
02/05/16 07:00 AMTechnical Recap on Biotechnology Equities -- Biogen, Medivation, Grifols, and Agios Pharma - [Accesswire] - NEW YORK, NY / ACCESSWIRE / February 05, 2016 / Park Lane Advisor has initiated coverage on the following equities: Biogen Inc. (NASDAQ: BIIB), Medivation Inc. (NASDAQ: MDVN), Grifols S.A. (NASDAQ: GRFS), ...
01/13/16 07:35 AMHow it All Plays Out - Analyst Reports on KapStone Paper and Packaging, Heartland Express, Grifols and Knoll - [Accesswire] - NEW YORK, NY / ACCESSWIRE / January 13, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: KapStone Paper ...
12/23/15 08:09 AM8 Biotech Stocks That Should Be in Your Portfolio Right Now -
About Grifols SA, Barcelona

Grifols SA, Barcelona logo

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: GRFS
  • CUSIP:
Key Metrics:
  • Previous Close: $16.08
  • 50 Day Moving Average: $15.81
  • 200 Day Moving Average: $15.54
  • P/E Ratio: 35.92
  • P/E Growth: 0.99
  • Market Cap: $21.19B
  • Current Quarter EPS Consensus Estimate: $1.04 EPS
Additional Links:
Grifols SA, Barcelona (NASDAQ:GRFS) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha